| Institution: | 1. Department of Public Health, University of Tartu, Tartu, Estonia;2. Centre for Health Equity Studies (CHESS), Stockholm University/Karolinska Institutet, Stockholm, Sweden;3. Estonian Drug Monitoring Center, National Institute for Health Development, Tallinn, Estonia;4. The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center New York, NY, United States;1. Department of Chemistry, Central Tehran Branch, Islamic Azad University, Tehran, Iran;2. TAM Pouya Pharmaceutical Research Co., Contract Research Organization Active in Pharmaceutical Analysis Section, Tehran, Iran;3. Department of Chemistry, Varamin (Pishva) Branch, Islamic Azad University, Varamin, Iran;1. Center for the Study of Health and Risk Behaviors, University of Washington, Seattle, WA, United States;2. Downtown Emergency Service Center, Seattle, WA, United States;3. Center for Healthcare Improvement for Addictions, Mental Illness and Medically Vulnerable Populations, University of Washington – Harborview, Seattle, WA, United States;1. Laboratory of Behavioral Neuroscience, Ningbo University, Ningbo, Zhejiang 315010, China;2. Ningbo Institute of Microcirculation and Henbane, Ningbo, Zhejiang 315010, China;3. Zhejiang Provincial Key Laboratory of Pathophysiology, Ningbo University School of Medicine, Ningbo 315211, China;4. Ningbo Addiction Research and Treatment Center, Ningbo, Zhejiang 315010, China |
